In breast cancer cell lines (MDA-MB-231 cell line), this synergistic effect is mediated by the phosphorylation of eif2α (serine 51) through a decreased of the expression of Nck1 (NCK Adaptor Protein 1), a potent inhibitor of eif2α phosphorylation [91]. The gene discussed is EIF2A; the disease is breast carcinoma.